$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 허혈성 뇌졸중 모델에서 혈액-뇌 장벽에 보호효과를 나타내는 한약처방, 한약재 및 활성화합물
Protective Effects of Traditional Korean Medicine Preparations, Herbs, and Active Compounds on the Blood-brain Barrier in Ischemic Stroke Models 원문보기

생명과학회지 = Journal of life science, v.32 no.7, 2022년, pp.550 - 566  

신수빈 (부산대학교 한의학전문대학원 한의학과) ,  장석주 (부산대학교 한의학전문대학원 한의학과) ,  이나경 (부산대학교 한의학전문대학원 한의학과) ,  최병태 (부산대학교 한의학전문대학원 한의학과) ,  신화경 (부산대학교 한의학전문대학원 한의학과)

초록
AI-Helper 아이콘AI-Helper

뇌졸중은 세계적으로 사망과 장기간인 신체적, 인지적 장애의 주요 원인들 중 하나이며, 매년 약 1,500만명의 사람들에게 영향을 미친다. 뇌졸중의 병태 생리학적 과정은 다수의 사건들이 관여하는 복잡한 과정으로, 그 중 혈액-뇌 장벽(blood-brain barrier: BBB)의 붕괴는 허혈성 뇌손상의 진행에 크게 기여하는 것으로 알려져 있다. 따라서 BBB 붕괴는 뇌졸중의 특징으로 인식되므로 허혈성 뇌졸중에서 BBB 기능 장애를 보호할 수 있는 새로운 치료 전략을 개발하는 것이 뇌졸중 치료에 매우 중요하다. 전통한약은 천연물로 구성되어 있으며, 이는 뇌졸중 치료약 개발을 위한 유망한 원천이 될 수 있다. 실제로 여러 연구에서 뇌졸중에 대한 한의학의 효능이 밝혀져 허혈성 뇌졸중에 대한 한의학적 치료 가치가 부각되고 있다. 본 리뷰에서는 허혈성 뇌졸중으로 인한 BBB 붕괴에 대한 전통적인 한의학의 처방, 탕약, 약재 및 활성 성분의 개선효과에 관한 현재 정보와 기본 메커니즘을 요약 정리하였다. 이러한 연구가 한의학의 신경보호 효과에 대한 추가 조사를 촉진하고 뇌졸중 환자에 대한 한방유래의 임상시험 시행을 활성화하는데 도움이 되기를 기대한다.

Abstract AI-Helper 아이콘AI-Helper

Stroke is among the leading causes of death and long-term physical and cognitive disabilities worldwide, affecting an estimated 15 million people annually. The pathophysiological process of stroke is complicated by multiple and coordinated events. The breakdown of the blood-brain barrier (BBB) in pe...

주제어

표/그림 (9)

AI 본문요약
AI-Helper 아이콘 AI-Helper

제안 방법

  • Traditional Korean medicine has been recorded in the treatment of neurovascular disorders. This review has presented several traditional Korean medicines, including the herbal formula, decoction, herbs, and active components, which exert a neuroprotective effect on cerebral ischemia-induced BBB disruption. These traditional medicines were shown to have protective effects on the BBB in many cellular ischemia models such as OGD and hypoxia, various animal ischemia models of stroke such as MCAO and photothrombosis, and experiments in various animal species such as mice and rats.
본문요약 정보가 도움이 되었나요?

참고문헌 (85)

  1. Ahmed, T., Raza, S. H., Maryam, A., Setzer, W. N., Braidy, N., Nabavi, S. F., de Oliveira, M. R. and Nabavi, S. M. 2016. Ginsenoside Rb1 as a neuroprotective agent: A review. Brain Res. Bull. 125, 30-43. 

  2. Bai, X., Tan, T. Y., Li, Y. X., Li, Y., Chen, Y. F., Ma, R., Wang, S. Y., Li, Q. and Liu, Z. Q. 2020. The protective effect of cordyceps sinensis extract on cerebral ischemic injury via modulating the mitochondrial respiratory chain and inhibiting the mitochondrial apoptotic pathway. Biomed. Pharmacother. 124, 109834. 

  3. Ballabh, P., Braun, A. and Nedergaard, M. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13. 

  4. Boehme, A. K., Esenwa, C. and Elkind, M. S. 2017. Stroke risk factors, genetics, and prevention. Circ. Res. 120, 472-495. 

  5. Cao, G., Jiang, N., Hu, Y., Zhang, Y., Wang, G., Yin, M., Ma, X., Zhou, K., Qi, J., Yu, B. and Kou, J. 2016. Ruscogenin attenuates cerebral ischemia-induced Blood-Brain Barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int. J. Mol. Sci. 17, 1418. 

  6. Cao, G., Ye, X., Xu, Y., Yin, M., Chen, H., Kou, J. and Yu, B. 2016. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice. Drug Des. Devel. Ther. 10, 315-325. 

  7. Cao, J., Wang, K., Lei, L., Bai, L., Liang, R., Qiao, Y., Duan, J., Gao, K., Cao, S., Zhao, C. and Yang, Z. 2020. Astragaloside and/or Hydroxysafflor Yellow A attenuates Oxygen-Glucose deprivation-induced cultured brain microvessel endothelial cell death through downregulation of PHLPP-1. Evid. Based Complement. Alternat. Med. 2020, 3597527. 

  8. Chang, L., Hu, L., Wei, C., Zhang, H. and Liu, S. 2020. Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice. J. Stroke Cerebrovasc. Dis. 29, 105071. 

  9. Chang, L. L., Li, C., Li, Z. L., Wei, Z. L., Jia, X. B., Pang, S. T., An, Y. Q., Gu, J. F. and Feng, L. 2020. Carthamus tinctorius L. Extract ameliorates cerebral ischemia-reperfusion injury in rats by regulating matrix metalloproteinases and apoptosis. Indian J. Pharmacol. 52, 108-116. 

  10. Chen, F. Q., Li, Q., Pan, C. S., Liu, Y. Y., Yan, L., Sun, K., Mao, X. W., Mu, H. N., Wang, M. X., Wang, C. S., Fan, J. Y., Cui, Y. C., Zhang, Y. P., Yang, J. Y., Bai, W. and Han, J. Y. 2016. Kudiezi Injection(®) alleviates blood-brain barrier disruption after ischemia-reperfusion in rats. Microcirculation 23, 426-437. 

  11. Chen, H., Guan, B., Chen, X., Chen, X., Li, C., Qiu, J., Yang, D., Liu, K. J., Qi, S. and Shen, J. 2018. Baicalin attenuates Blood-Brain Barrier disruption and hemorrhagic transformation and improves neurological outcome in ischemic stroke rats with delayed t-PA treatment: Involvement of ONOO(-)-MMP-9 pathway. Transl. Stroke Res. 9, 515-529. 

  12. Chen, H., He, Y., Chen, S., Qi, S. and Shen, J. 2020. Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology. Pharmacol. Res. 158, 104877. 

  13. Chen, H. J., Shen, Y. C., Shiao, Y. J., Liou, K. T., Hsu, W. H., Hsieh, P. H., Lee, C. Y., Chen, Y. R. and Lin, Y. L. 2015. Multiplex brain proteomic analysis revealed the molecular therapeutic effects of Buyang Huanwu Decoction on cerebral ischemic stroke mice. PLoS One 10, e0140823. 

  14. Chen, W., Guo, Y., Yang, W., Zheng, P., Zeng, J. and Tong, W. 2015. Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia. Exp. Brain. Res. 233, 2823-2831. 

  15. Chen, Z. X., Xu, Q. Q., Shan, C. S., Shi, Y. H., Wang, Y., Chang, R. C. and Zheng, G. Q. 2019. Borneol for regulating the permeability of the Blood-Brain Barrier in experimental ischemic stroke: Preclinical evidence and possible mechanism. Oxid. Med. Cell. Longev. 2019, 2936737. 

  16. Choi, M. J., Choi, B. T., Shin, H. K., Shin, B. C., Han, Y. K. and Baek, J. U. 2015. Establishment of a comprehensive list of candidate antiaging medicinal herb used in Korean Medicine by text mining of the classical Korean Medical literature, "Dongeuibogam," and preliminary evaluation of the antiaging effects of these herbs. Evid. Based Complement. Alternat. Med. 2015, 873185. 

  17. Colombo, E. and Farina, C. 2016. Astrocytes: Key regulators of neuroinflammation. Trends Immunol. 37, 608-620. 

  18. Cui, Z., Liu, S., Hou, L., Sun, Y., Chen, H., Mao, H., Zhao, Y. and Qiao, L. 2021. Effect of Tongfu Xingshen capsule on the endogenous neural stem cells of experimental rats with intracerebral hemorrhage. Mol. Med. Report. 24, 624. 

  19. Daneman, R. and Prat, A. 2015. The blood-brain barrier. Cold Spring Harb. Perspect. Biol. 7, a020412. 

  20. Daneman, R., Zhou, L., Kebede, A. A. and Barres, B. A. 2010. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566. 

  21. Dong, T., Chen, N., Ma, X., Wang, J., Wen, J., Xie, Q. and Ma, R. 2018. The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit. Biomed. Pharmacother. 102, 874-883. 

  22. Dou, B., Zhou, W., Li, S., Wang, L., Wu, X., Li, Y., Guan, H., Wang, C., Zhu, S., Ke, Z., Huang, C. and Wang, Z. 2018. Buyang Huanwu Decoction attenuates infiltration of Natural Killer cells and protects against ischemic brain injury. Cell. Physiol. Biochem. 50, 1286-1300. 

  23. Fan, F., Yang, L., Li, R., Zou, X., Li, N., Meng, X., Zhang, Y. and Wang, X. 2020. Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety. Biomed. Pharmacother. 129, 110458. 

  24. Forster, A., Brown, L., Smith, J., House, A., Knapp, P., Wright, J. J. and Young, J. 2012. Information provision for stroke patients and their caregivers. Cochrane Database Syst. Rev. 11, Cd001919. 

  25. He, F., Duan, X., Dai, R., Wang, W., Yang, C. and Lin, Q. 2016. Protective effects of ethyl acetate extraction from Gastrodia elata blume on blood-brain barrier in focal cerebral ischemia reperfusion. Afr. J. Tradit. Complement. Altern. Med. 13, 199-209. 

  26. Hu, S., Wu, Y., Zhao, B., Hu, H., Zhu, B., Sun, Z., Li, P. and Du, S. 2018. Panax notoginseng Saponins protect cerebral microvascular endothelial cells against oxygenglucose deprivation/reperfusion-induced barrier dysfunction via activation of PI3K/Akt/Nrf2 antioxidant signaling pathway. Molecules 23, 2781. 

  27. Hughes, R. E., Tadi, P. and Bollu, P. C. 2022. TPA Therapy, StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.: Treasure Island (FL). 

  28. Ishida, H., Takemori, K., Dote, K. and Ito, H. 2006. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am. J. Hypertens. 19, 33-39. 

  29. Jiang, W., Fu, F., Tian, J., Zhu, H. and Hou, J. 2011. Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo. Neuroscience 192, 572-579. 

  30. Jin, Z., Liang, J. and Kolattukudy, P. E. 2021. Tetramethylpyrazine preserves the integrity of Blood-Brain Barrier associated with upregulation of MCPIP1 in a murine model of focal ischemic stroke. Front. Pharmacol. 12, 710358. 

  31. Kim, M. J., Lee, S. Y., Hwang, J. Y., Kim, H., Ha, K. T., Choi, B. T., Baek, J. U. and Shin, H. K. 2018. Pretreatment with Shuanghe-Tang Extract attenuates postischemic brain injury and edema in a mouse model of stroke: An analysis of medicinal herbs listed in Dongui Bogam. Oxid. Med. Cell. Longev. 2018, 2479602. 

  32. Kim, M. J., Park, K. H., Lee, J. Y., Ha, K. T., Choi, B. T., Baek, J. U., Yun, Y. J., Lee, S. Y. and Shin, H. K. 2019. Weisheng-Tang ameliorates acute ishemic brain damage in mice by maintaining Blood-Brain Barrier integrity. Oxid. Med. Cell. Longev. 2019, 4379732. 

  33. Koehn, F. E. and Carter, G. T. 2005. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4, 206-220. 

  34. Li, L., Cheng, S. Q., Guo, W., Cai, Z. Y., Sun, Y. Q., Huang, X. X., Yang, J., Ji, J., Chen, Y. Y., Dong, Y. F., Cheng, H. and Sun, X. L. 2021. Oridonin prevents oxidative stress-induced endothelial injury via promoting Nrf-2 pathway in ischaemic stroke. J. Cell. Mol. Med. 25, 9753-9766. 

  35. Li, L., Wang, N., Jin, Q., Wu, Q., Liu, Y. and Wang, Y. 2017. Protection of Tong-Qiao-Huo-Xue Decoction against cerebral ischemic injury through reduction Blood-Brain Barrier permeability. Chem. Pharm. Bull (Tokyo). 65, 1004-1010. 

  36. Li, M., Li, S. C., Dou, B. K., Zou, Y. X., Han, H. Z., Liu, D. X., Ke, Z. J. and Wang, Z. F. 2020. Cycloastragenol upregulates SIRT1 expression, attenuates apoptosis and suppresses neuroinflammation after brain ischemia. Acta Pharmacol. Sin. 41, 1025-1032. 

  37. Li, N., Wang, J., Ma, J., Gu, Z., Jiang, C., Yu, L. and Fu, X. 2015. Neuroprotective effects of Cistanches Herba therapy on patients with moderate Alzheimer's disease. Evid. Based Complement. Alternat. Med. 2015, 103985. 

  38. Li, Y., Cai, M., Mao, G. X., Shu, Q. F., Liu, X. B. and Liu, X. L. 2021. Preclinical evidence and possible mechanisms of Rhodiola rosea L. and its components for ischemic stroke: A systematic review and meta-analysis. Front. Pharmacol. 12, 736198. 

  39. Li, Y., Ren, M., Wang, J., Ma, R., Chen, H., Xie, Q., Li, H., Li, J. and Wang, J. 2021. Progress in Borneol intervention for ischemic stroke: A systematic review. Front. Pharmacol. 12, 606682. 

  40. Liang, W., Huang, X. and Chen, W. 2017. The effects of Baicalin and Baicalein on cerebral ischemia: A review. Aging Dis. 8, 850-867. 

  41. Lin, M., Sun, W., Gong, W., Ding, Y., Zhuang, Y. and Hou, Q. 2015. Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats. Acta Pharmacol. Sin. 5, 277-284. 

  42. Lin, M., Sun, W., Gong, W., Zhou, Z., Ding, Y. and Hou, Q. 2015. Methylophiopogonanone A protects against cerebral ischemia/reperfusion injury and attenuates Blood-Brain Barrier disruption in vitro. PLoS One 10, e0124558. 

  43. Liu, G., Liang, Y., Xu, M., Sun, M., Sun, W., Zhou, Y., Huang, X., Song, W., Liang, Y. and Wang, Z. 2021. Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats. Sci. Rep. 11, 18451. 

  44. Liu, S., Chang, L. and Wei, C. 2019. The sonic hedgehog pathway mediates Tongxinluo capsule-induced protection against blood-brain barrier disruption after ischaemic stroke in mice. Basic Clin. Pharmacol. Toxicol. 124, 660-669. 

  45. Liu, X., Jin, X., Chen, B., Liu, X., Liang, X., Fang, X., Wu, H., Fu, X., Zheng, H., Ding, X., Duan, N. and Zhang, Y. 2018. Effects of Kudiezi Injection on serum inflammatory biomarkers in patients with acute cerebral infarction. Dis. Markers. 2018, 7936736. 

  46. Liu, X., Wang, Z., Wang, P., Yu, B., Liu, Y. and Xue, Y. 2013. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement. Altern. Med. 13, 187. 

  47. Liu, Z. and Chopp, M. 2016. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog. Neurobiol. 144, 103-120. 

  48. Lv, L., Liu, Y., Shi, H. F. and Dong, Q. 2009. Qingkailing injection attenuates apoptosis and neurologic deficits in a rat model of intracerebral hemorrhage. J. Ethnopharmacol. 125, 269-273. 

  49. Ma, C., Wang, X., Xu, T., Yu, X., Zhang, S., Liu, S., Gao, Y., Fan, S., Li, C., Zhai, C., Cheng, F. and Wang, Q. 2019. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 inflammasome signalling pathway. BMC Complement. Altern. Med. 19, 320. 

  50. Ma, C., Wang, X., Xu, T., Zhang, S., Liu, S., Zhai, C., Wang, Z., Mu, J., Li, C., Cheng, F. and Wang, Q. 2020. An integrative pharmacology-based analysis of refined Qingkailing Injection against cerebral ischemic stroke: A novel combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid. Front. Pharmacol. 11, 519. 

  51. Mao, X. W., Pan, C. S., Huang, P., Liu, Y. Y., Wang, C. S., Yan, L., Hu, B. H., Chang, X., He, K., Mu, H. N., Li, Q., Sun, K., Fan, J. Y. and Han, J. Y. 2015. Levo-tetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: Involvement of Src kinase. Sci. Rep. 5, 11155. 

  52. May, B. H., Lu, C., Bennett, L., Hugel, H. M. and Xue, C. C. 2012. Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment. Biogerontology 13, 299-312. 

  53. Michinaga, S. and Koyama, Y. 2015. Pathogenesis of brain edema and investigation into anti-edema drugs. Int. J. Mol. Sci. 16, 9949-9975. 

  54. Nakagomi, T., Kubo, S., Nakano-Doi, A., Sakuma, R., Lu, S., Narita, A., Kawahara, M., Taguchi, A. and Matsuyama, T. 2015. Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. Stem Cells 33, 1962-1974. 

  55. Ni, C., Zeng, N., Xu, F., Gou, L., Liu, J., Wang, J. and Xia, H. 2011. Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats. Zhongguo Zhong Yao Za Zhi 36, 2562-2566. 

  56. Nour, M., Scalzo, F. and Liebeskind, D. S. 2013. Ischemiareperfusion injury in stroke. J. Vasc. Interv. Neurol. 1, 185-199. 

  57. Park, M. Y., Jung, Y. S., Park, J. H., Choi, Y. W., Lee, J., Kim, C. M., Baek, J. U., Choi, B. T. and Shin, H. K. 2015. PMC-12, a prescription of Traditional Korean Medicine, improves Amyloid β-Induced cognitive deficits through modulation of neuroinflammation. Evid. Based Complement. Alternat. Med. 2015, 768049. 

  58. Qu, Y. Z., Li, M., Zhao, Y. L., Zhao, Z. W., Wei, X. Y., Liu, J. P., Gao, L. and Gao, G. D. 2009. Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats. Eur. J. Pharmacol. 606, 137-141. 

  59. Rosell, A. and Lo, E. H. 2008. Multiphasic roles for matrix metalloproteinases after stroke. Curr. Opin. Pharmacol. 8, 82-89. 

  60. Seo, H. B., Kang, B. K., Kim, J. H., Choi, Y. W., Hong, J. W., Choi, B. T. and Shin, H. K. 2015. Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice. BMC Complement. Altern. Med. 15, 157. 

  61. Sun, Z. Y., Wang, F. J., Guo, H., Chen, L., Chai, L. J., Li, R. L., Hu, L. M., Wang, H. and Wang, S. X. 2019. Shuxuetong injection protects cerebral microvascular endothelial cells against oxygen-glucose deprivation reperfusion. Neural Regen. Res. 14, 783-793. 

  62. Tan, F., Fu, W., Cheng, N., Meng, D. I. and Gu, Y. 2015. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp. Ther. Med. 9, 1757-1762. 

  63. Tsoi, B., Chen, X., Gao, C., Wang, S., Yuen, S. C., Yang, D. and Shen, J. 2019. Neuroprotective effects and hepatorenal toxicity of Angong Niuhuang Wan against ischemia-reperfusion brain injury in rats. Front. Pharmacol. 10, 593. 

  64. Tu, X. K., Yang, W. Z., Liang, R. S., Shi, S. S., Chen, J. P., Chen, C. M., Wang, C. H., Xie, H. S., Chen, Y. and Ouyang, L. Q. 2011. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem. Res. 36, 2022-2028. 

  65. Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., Lackland, D. T., Lewis, T. T., Lichtman, J. H., Longenecker, C. T., Loop, M. S., Lutsey, P. L., Martin, S. S., Matsushita, K., Moran, A. E., Mussolino, M. E., Perak, A. M., Rosamond, W. D., Roth, G. A., Sampson, U. K. A., Satou, G. M., Schroeder, E. B., Shah, S. H., Shay, C. M., Spartano, N. L., Stokes, A., Tirschwell, D. L., VanWagner, L. B. and Tsao, C. W. 2020. Heart disease and stroke statistics-2020 update: A report from the American Heart Association. Circulation 141, e139-e596. 

  66. Wang, B., Lyu, Z., Chan, Y., Li, Q., Zhang, L., Liu, K., Li, Y. and Yu, Z. 2021. Tongxinluo exerts inhibitory effects on pyroptosis and amyloid-β peptide accumulation after cerebral ischemia/reperfusion in rats. Evid. Based Complement. Alternat. Med. 2021, 5788602. 

  67. Wang, F., Li, R., Tu, P., Chen, J., Zeng, K. and Jiang, Y. 2020. Total glycosides of Cistanche deserticola promote neurological function recovery by inducing neurovascular regeneration via Nrf-2/Keap-1 pathway in MCAO/R rats. Front. Pharmacol. 11, 236. 

  68. Wang, L., Li, Z., Zhang, X., Wang, S., Zhu, C., Miao, J., Chen, L., Cui, L. and Qiao, H. 2014. Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability. Neurochem. Res. 39, 97-106. 

  69. Wang, S., Guo, H., Wang, X., Chai, L., Hu, L., Zhao, T., Zhao, B., Tan, X. and Jia, F. 2014. Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury. Neural Regen. Res. 9, 1453-1459. 

  70. Wolburg, H. and Lippoldt, A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337. 

  71. Woodruff, T. M., Thundyil, J., Tang, S.-C., Sobey, C. G., Taylor, S. M. and Arumugam, T. V. 2011. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol. Neurodegener. 6, 11. 

  72. Wu, S. P., Wang, N. and Zhao, L. 2020. Network pharmacology reveals the mechanism of activity of Tongqiao Huoxue Decoction extract against middle cerebral artery occlusion-induced cerebral ischemia-reperfusion injury. Front. Pharmacol. 11, 572624. 

  73. Xie, W., Wang, X., Xiao, T., Cao, Y., Wu, Y., Yang, D. and Zhang, S. 2021. Protective effects and network analysis of Ginsenoside Rb1 against cerebral ischemia injury: A pharmacological review. Front. Pharmacol. 12, 604811. 

  74. Xie, W., Zhu, T., Dong, X., Nan, F., Meng, X., Zhou, P., Sun, G. and Sun, X. 2019. HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways. Biomolecules 9, 512. 

  75. Xue, Q., Liu, Y., He, R., Yang, S., Tong, J., Li, X., Chen, Y. and Xu, X. 2016. Lyophilized powder of Catalpol and Puerarin protects neurovascular unit from stroke. Int. J. Biol. Sci. 12, 367-380. 

  76. Yang, D., Li, S. Y., Yeung, C. M., Chang, R. C., So, K. F., Wong, D. and Lo, A. C. 2012. Lycium barbarum extracts protect the brain from blood-brain barrier disruption and cerebral edema in experimental stroke. PLoS One 7, e33596. 

  77. Yang, P., Tian, Y. M., Deng, W. X., Cai, X., Liu, W. H., Li, L. and Huang, H. Y. 2019. Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats. Exp. Ther. Med. 18, 2805-2812. 

  78. Yang, W., Zhang, L., Chen, S., Yao, Q., Chen, H., Zhou, J., Chen, W., He, L. and Zhang, Y. 2020. Longshengzhi Capsules improve ischemic stroke outcomes and reperfusion injury via the promotion of anti-inflammatory and neuroprotective effects in MCAO/R rats. Evid. Based Complement. Alternat. Med. 2020, 9654175. 

  79. Yin, Y. Y., Li, W. P., Gong, H. L., Zhu, F. F., Li, W. Z. and Wu, G. C. 2010. Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats. Am. J. Chin. Med. 38, 517-527. 

  80. Zeng, M., Zhou, H., He, Y., Du, H., Yin, J., Hou, Y., Zhu, J., Zhang, Y., Shao, C., Yang, J. and Wan, H. 2021. Danhong injection enhances the therapeutic effect of mannitol on hemispheric ischemic stroke by ameliorating bloodbrain barrier disruption. Biomed. Pharmacother. 142, 112048. 

  81. Zhang, S., Wang, X., Cheng, F., Ma, C., Fan, S., Xu, W., Jin, N., Liu, S., Lv, K. and Wang, Q. 2020. Network pharmacology-based approach to revealing biological mechanisms of qingkailing injection against ischemicstroke: focusing on blood-brain barrier. Evid. Based Complement. Alternat. Med. 2020, 2914579. 

  82. Zhou, Y., Li, H. Q., Lu, L., Fu, D. L., Liu, A. J., Li, J. H. and Zheng, G. Q. 2014. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine 21, 998-1003. 

  83. Zhu, H., Wang, Z., Xing, Y., Gao, Y., Ma, T., Lou, L., Lou, J., Gao, Y., Wang, S. and Wang, Y. 2012. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. J. Ethnopharmacol. 141, 714-720. 

  84. Zivin, J. A. 2009. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann. Neurol. 66, 6-10. 

  85. Zuo, W., Yan, F., Zhang, B., Hu, X. and Mei, D. 2018. Salidroside improves brain ischemic injury by activating PI3K/Akt pathway and reduces complications induced by delayed tPA treatment. Eur. J. Pharmacol. 830, 128-138. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로